Takeda Pharmaceuticals USA Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Takeda Pharmaceuticals USA Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013912
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Takeda Pharmaceuticals USA Inc (TPUSA), formerly Takeda Pharmaceuticals North America Inc, a subsidiary of Takeda Pharmaceutical Company Ltd, is a developer, manufacturer and distributor of pharmaceutical drugs. The company’s products include pioglitazone and glimepiride, lubiprostone, pioglitazone, pioglitazone and metformin HCl, azilsartan medoxomil, alogliptin, peginesatide, lansoprazole, colchicine, USP, dexlansoprazole, ramelteon and febuxostat. It offers products in therapeutic areas including cardiovascular disease, central nervous system disorders, bone and joint disorders, gastroenterology, gynecology disorders, kidney disorders and other infectious diseases. TPUSA conducts research and development activities to develop new drugs. The company markets its products through its distributors in the US. TPUSA is headquartered in Deerfield, Illinois, the US.

Takeda Pharmaceuticals USA Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Takeda Pharma Enters into Research Agreement with University of Chicago and Icahn School of Medicine at Mount Sinai 10
Prasco Lab Enters into Co-Marketing Agreement with Takeda Pharma 11
Affymax Enters Into Co-Promotion Agreement With Takeda For Peginesatide 12
Teijin Pharma Enters Into Co-Marketing Agreement With Takeda Pharma North America For TMX-67 13
Asset Transactions 14
Caraco Pharma Completes Acquisition Of Non-Colcrys Business Of URL Pharma From Takeda Pharma For US$65 Million 14
Takeda Pharmaceuticals USA Inc – Key Competitors 15
Takeda Pharmaceuticals USA Inc – Key Employees 16
Takeda Pharmaceuticals USA Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Oct 06, 2017: Takeda Donates $100,000 to Local, Regional Charities as Part of Company’s Takeda Cares Day Event 18
Other Significant Developments 19
Sep 07, 2016: Takeda Launches Wearable Digital Technology Pilot Program to Support Patients and Healthcare Providers with Inflammatory Bowel Disease Management 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Key Facts 2
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Takeda Pharmaceuticals USA Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Takeda Pharma Enters into Research Agreement with University of Chicago and Icahn School of Medicine at Mount Sinai 10
Prasco Lab Enters into Co-Marketing Agreement with Takeda Pharma 11
Affymax Enters Into Co-Promotion Agreement With Takeda For Peginesatide 12
Teijin Pharma Enters Into Co-Marketing Agreement With Takeda Pharma North America For TMX-67 13
Caraco Pharma Completes Acquisition Of Non-Colcrys Business Of URL Pharma From Takeda Pharma For US$65 Million 14
Takeda Pharmaceuticals USA Inc, Key Competitors 15
Takeda Pharmaceuticals USA Inc, Key Employees 16

★海外企業調査レポート[Takeda Pharmaceuticals USA Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fujimori Kogyo Co., Ltd. (7917):企業の財務・戦略的SWOT分析
    Fujimori Kogyo Co., Ltd. (7917) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Petrochemical Corporation of Singapore (Private) Ltd:企業の戦略的SWOT分析
    Petrochemical Corporation of Singapore (Private) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key comp …
  • BaroFold Inc-製薬・医療分野:企業M&A・提携分析
    Summary BaroFold Inc (BaroFold) is a biotechnology company that provides protein refolding services. The company offers services such as research study services, optimization study services, and process implementation services. Its optimization study services include confirm analytical services, res …
  • Provogue (India) Limited (PROVOGE):企業の財務・戦略的SWOT分析
    Provogue (India) Limited (PROVOGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Moderna Therapeutics Inc:企業のM&A・事業提携・投資動向
    Moderna Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Moderna Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • PNE Wind AG (PNE3)-エネルギー分野:企業M&A・提携分析
    Summary PNE Wind AG (PNE) is a renewable energy company. It has a presence in the entire value added chain in the wind energy sector. The company develops, manages projects, realizes, finances, and operates wind-farm projects. PNE also offers commercial and technical operating management services fo …
  • US Physical Therapy Inc (USPH):製薬・医療:M&Aディール及び事業提携情報
    Summary US Physical Therapy Inc (USPh) operates outpatient physical and occupational therapy clinics that offer pre-and post-operative care. The company provides treatment for orthopedic-related disorders, preventative care, sports-related injuries, rehabilitation of injured workers and neurological …
  • Aalberts Industries NV:企業の戦略・SWOT・財務分析
    Aalberts Industries NV - Strategy, SWOT and Corporate Finance Report Summary Aalberts Industries NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • JBCC Holdings Inc (9889):企業の財務・戦略的SWOT分析
    JBCC Holdings Inc (9889) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • B. Braun Melsungen AG-製薬・医療分野:企業M&A・提携分析
    Summary B. Braun Melsungen AG (B. Braun) is a global health care company. It offers products and solutions for therapy fields and applications including acute dialysis, infusion therapy, apheresis, interventional vascular, diagnostics and treatment, cardio-thoracic surgery, laparoscopy, degenerative …
  • BJ’s Wholesale Club Inc:企業の戦略・SWOT・財務分析
    BJ's Wholesale Club Inc - Strategy, SWOT and Corporate Finance Report Summary BJ's Wholesale Club Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Max Hamburgerrestauranger AB:戦略・SWOT・企業財務分析
    Max Hamburgerrestauranger AB - Strategy, SWOT and Corporate Finance Report Summary Max Hamburgerrestauranger AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Banca Sella Holding SpA:企業の戦略的SWOT分析
    Banca Sella Holding SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Essential Energy Services Ltd (ESN):石油・ガス:M&Aディール及び事業提携情報
    Summary Essential Energy Services Ltd (Essential Energy) is an oil and gas company that offers oilfield services. The company provides coil well services and tool services. Its services include coil tubing, fluid and nitrogen pumping, completion, abandonment, and downhole tools and equipment rental …
  • Volvo Car Corporation:企業の戦略・SWOT・財務分析
    Volvo Car Corporation - Strategy, SWOT and Corporate Finance Report Summary Volvo Car Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bayshore Petroleum Corp (BSH):企業の財務・戦略的SWOT分析
    Summary Bayshore Petroleum Corp (Bayshore Petroleum) is an oil and gas company that explores, produces, and develops natural gas and petroleum. The company develops conventional and unconventional oil and gas prospects in North America and across the world. It utilizes CCC technology for heavy oil a …
  • Royal Dutch Shell Plc (RDSA):企業の財務・戦略的SWOT分析
    Royal Dutch Shell Plc (RDSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Vidrala S.A.:企業の戦略・SWOT・財務情報
    Vidrala S.A. - Strategy, SWOT and Corporate Finance Report Summary Vidrala S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • SunPower Corporation (SPWR):電力:M&Aディール及び事業提携情報
    Summary SunPower Corporation (SunPower), a subsidiary of Total Solar International SAS, is a provider of solar technology and energy services. The company has a presence in solar value chain from cell and panel manufacturing, project development, project finance through engineering, procurement, and …
  • Huntington Memorial Hospital:企業の戦略的SWOT分析
    Huntington Memorial Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆